Rockville, MD, United States of America

Ronald L Rabin

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Leland Stanford Junior University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1999-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald L Rabin. Retrieved from https://idiyas.com/inventor/ronald-l-rabin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1999-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Ronald L Rabin

Introduction

Ronald L Rabin is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of human interferon-alpha subtypes and rapid assays for infections in immunocompromised patients. With a total of 3 patents, his work has had a profound impact on healthcare and patient management.

Latest Patents

One of his latest patents is focused on "Compositions for detecting human interferon-alpha subtypes and methods of use." This invention provides highly sensitive, specific, and efficient quantitative real-time PCR compositions, methods, and assay kits to detect at least one IFN subtype and/or IFN subtype allotypic variants. The primer/probe sets designed for this purpose enhance the correlation between the measured IFN subtype and the protein that is expressed. This invention is particularly useful for monitoring vaccine efficacy, autoimmune diseases, chronic infections, or tumor therapy.

Another significant patent is the "Rapid assay for infection in neonates." This rapid assay allows for the diagnosis of infections in immunodeficient patients, such as neonates or those with compromised immune systems. By enabling diagnosis at initial evaluation, the assay helps avoid unnecessary antibiotic treatment and confinement to intensive care units for uninfected patients. The method is especially beneficial for diagnosing sepsis by measuring polymorphonuclear leukocyte (PMN, neutrophil) CD11b levels in low volume whole blood samples.

Career Highlights

Throughout his career, Ronald L Rabin has worked with prestigious institutions, including Leland Stanford Junior University and the United States Department of Health and Human Services. His innovative work has contributed to advancements in medical diagnostics and patient care.

Collaborations

Rabin has collaborated with notable individuals in his field, including Leonore A Herzenberg and Leonard A Herzenberg. Their combined expertise has furthered the development of diagnostic methods and technologies.

Conclusion

Ronald L Rabin's contributions to medical diagnostics through his patents and collaborations have significantly advanced the field. His innovative approaches continue to influence healthcare practices and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…